In ccRCC, the upregulation of ENO2 is regulated by FOXC1(Fig 4B), which promotes glycolysis and supports the Warburg effect—a metabolic shift observed in many cancers where cells rely on glycolysis for energy production even in the presence of oxygen [154]. Here, FOXC1 is linked to nonpapillary renal cell carcinoma.